Related Experiment Video
Updated: May 13, 2026
10:28
Isolation of Primary Mouse Trophoblast Cells and Trophoblast Invasion Assay
Published on: January 8, 2012
Gestational trophoblastic diseases in Turkey
1Department of Obstetrics and Gynecology, Eskisehir Osmangazi University School of Medicine, Eskisehir, Turkey.
The Journal of Reproductive Medicine
|March 2, 2013
Summary
Hydatidiform mole (HM) incidence in Turkey is high, varying by study type. More community-based research is needed for accurate data and improved patient care through multidisciplinary teams.
Area of Science:
- Gynecology
- Obstetrics
- Epidemiology
Background:
- Hydatidiform mole (HM) is a gestational trophoblastic disease with significant epidemiological variations.
- Accurate incidence data and standardized management protocols are crucial for patient outcomes.
Purpose of the Study:
- To comprehensively evaluate the epidemiology, staging, prognostic scoring, immunohistochemistry, management, and outcomes of hydatidiform mole in Turkey.
- To analyze existing literature and identify gaps in current knowledge regarding HM in the Turkish population.
Main Methods:
- Retrospective analysis of all published Turkish literature on hydatidiform mole from 1932 to 2011.
- Inclusion of data from hospital-based studies and a specific epidemiological field study in rural Turkey.
Main Results:
- Reported HM incidence rates varied widely (0.3-16 per 1,000 pregnancies).
- Overall average incidence was 2.39 per 1,000 pregnancies and 1.87 per 1,000 deliveries across 929,323 pregnancies.
- A rural field study reported lower rates (0.8 per 1,000 live births, 0.6 per 1,000 pregnancies), highlighting the impact of study origin.
Conclusions:
- Multicenter, community-based studies are essential to determine the true incidence of hydatidiform mole in Turkey.
- Establishing national registries and ensuring multidisciplinary team management for gestational trophoblastic disease are vital for optimal patient care.
Related Concept Videos
01:07Teratogenicity
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
02:07Oogenesis
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...